Does CILTACABTAGENE AUTOLEUCEL Cause Product packaging issue? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Product packaging issue have been filed in association with CILTACABTAGENE AUTOLEUCEL (CARVYKTI). This represents 0.2% of all adverse event reports for CILTACABTAGENE AUTOLEUCEL.
7
Reports of Product packaging issue with CILTACABTAGENE AUTOLEUCEL
0.2%
of all CILTACABTAGENE AUTOLEUCEL reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging issue From CILTACABTAGENE AUTOLEUCEL?
Of the 7 reports.
Is Product packaging issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CILTACABTAGENE AUTOLEUCEL. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does CILTACABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (570)
Pyrexia (242)
Immune effector cell-associated neurotoxicity syndrome (232)
Parkinsonism (209)
Hospitalisation (193)
Adverse event (143)
Neurotoxicity (140)
Death (130)
Malaise (126)
Fatigue (123)
What Other Drugs Cause Product packaging issue?
ACETAMINOPHEN (448)
LOPERAMIDE (351)
DIMETHICONE\LOPERAMIDE (348)
USTEKINUMAB (221)
FENTANYL (200)
MINOXIDIL (173)
CETIRIZINE (166)
ESTRADIOL (163)
GOLIMUMAB (95)
CYCLOSPORINE (93)
Which CILTACABTAGENE AUTOLEUCEL Alternatives Have Lower Product packaging issue Risk?
CILTACABTAGENE AUTOLEUCEL vs CIMETIDINE
CILTACABTAGENE AUTOLEUCEL vs CIMZIA
CILTACABTAGENE AUTOLEUCEL vs CINACALCET
CILTACABTAGENE AUTOLEUCEL vs CINNARIZINE
CILTACABTAGENE AUTOLEUCEL vs CINRYZE